LCTX stock news
This page provides real-time market news, earnings updates, and company announcements related to Lineage Cell Therapeutics, Inc. (LCTX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 02:22 EST
Cronos Launches New All-in-One Vape, Spinach PUFFERZ
Finviz2026-02-17 12:33:44
Scotiabank Maintains Hold on Lineage (LINE) as Analysts Stay Cautious
Finviz2026-02-17 13:21:43
Scotiabank Maintains Hold on Lineage (LINE) as Analysts Stay Cautious
Finviz2026-02-17 13:24:37
Mesoblast Financial Results and Corporate Update Webcast
Finviz2026-02-20 12:03:41
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-20 21:18:06
Mizuho Lowers its Price Target on Netskope, Inc. (NTSK) to $20 and Maintains an Outperform Rating
Finviz2026-02-25 06:48:06
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-02-26 14:06:40
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
PLTR's Foundry and Gotham Accelerate Enterprise AI Expansion
Finviz2026-03-03 15:18:45
Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
Finviz2026-03-05 23:33:48
Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO Strength
Finviz2026-03-10 01:36:58
EXL unveils new agentic AI solutions to accelerate enterprise transformation across the full AI value chain
Finviz2026-03-11 12:37:20
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
Finviz2026-03-11 23:24:50
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-16 11:03:45
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-16 22:06:42
ORIC Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Finviz2026-03-17 21:06:50
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
Finviz2026-03-23 20:09:47
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
Finviz2026-03-26 20:03:52
Nurix Therapeutics to Participate in Upcoming Investor Conference
Finviz2026-04-07 11:03:42
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Finviz2026-04-08 10:03:59
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-20 21:18:06
Mizuho Lowers its Price Target on Netskope, Inc. (NTSK) to $20 and Maintains an Outperform Rating
Finviz2026-02-25 06:48:06
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-02-26 14:06:40
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:03:45
PLTR's Foundry and Gotham Accelerate Enterprise AI Expansion
Finviz2026-03-03 15:18:45
Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
Finviz2026-03-05 23:33:48
Lineage (LINE) Price Target Increased to $44 by RBC Capital on Q4 FFO Strength
Finviz2026-03-10 01:36:58
EXL unveils new agentic AI solutions to accelerate enterprise transformation across the full AI value chain
Finviz2026-03-11 12:37:20
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
Finviz2026-03-11 23:24:50
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-16 11:03:45
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-16 22:06:42
ORIC Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Finviz2026-03-17 21:06:50
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
Finviz2026-03-23 20:09:47
Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock
Finviz2026-03-26 20:03:52
Nurix Therapeutics to Participate in Upcoming Investor Conference
Finviz2026-04-07 11:03:42
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy
Finviz2026-04-08 03:36:58
Nurix Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Finviz2026-04-08 10:03:59
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy - CORRECTION
Finviz2026-04-10 20:12:45
LCTX stock chart
LCTX stock detailsLCTX stock price change
On the last trading day, LCTX stock closed at 1.63 USD, with a price change of 2.52% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more